Provided By PR Newswire
Last update: Feb 4, 2025
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. ("Kyverna" or the "Company") (NASDAQ: KYTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read more at prnewswire.comNASDAQ:KYTX (8/1/2025, 8:00:02 PM)
3.44
-0.13 (-3.64%)
Find more stocks in the Stock Screener